Viral vectored transmission blocking vaccines against Plasmodium falciparum
Background: Transmission blocking vaccines (TBVs) target sexual develop¬ment of the parasite within the mosquito and aim to prevent transmission of malaria from one individual to another. Antibodies raised against Pfs48/45, Pfs230 Region C, PfHAP2, and Anopheles gambiae Alanyl Aminopeptidase N1 (Ag...
Main Authors: | Kapulu, M, Biswas, S, Blagborough, A, Gilbert, S, Sinden, R, Hill, A |
---|---|
Format: | Journal article |
Published: |
BioMed Central
2010
|
Similar Items
-
Viral vectored transmission blocking vaccines against <it>Plasmodium falciparum</it>
by: Sinden Robert E, et al.
Published: (2010-10-01) -
Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.
by: Mizutani, M, et al.
Published: (2014) -
A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity.
by: Goodman, A, et al.
Published: (2011) -
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
by: Kapulu, MC
Published: (2014) -
Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro.
by: Blagborough, A, et al.
Published: (2009)